GE低分子量蛋白標(biāo)準(zhǔn)(GE17-0446-01)使用說(shuō)明書*，*，庫(kù)存現(xiàn)貨，無(wú)效果，免費(fèi)退款。公司現(xiàn)貨銷售，量大折扣，咨詢。詳細(xì)信息如下。
| 產(chǎn)品名稱 | 英文名稱 | 包裝 |
| GE低分子量蛋白標(biāo)準(zhǔn)(GE17-0446-01)使用說(shuō)明書 | GE LMW-SDS Marker Kit | 可根據(jù)客戶要求訂制 |
GE低分子量蛋白標(biāo)準(zhǔn)(GE17-0446-01)使用說(shuō)明書描述及應(yīng)用：
通過(guò)和標(biāo)準(zhǔn)樣品對(duì)比，用PAGE檢測(cè)未知樣品蛋白含量。
特點(diǎn)：
根據(jù)遷移距離，可得清晰的條帶。
通過(guò)考馬斯亮藍(lán)法或銀染法，可得到肉眼可見(jiàn)的蛋白染色條帶。
產(chǎn)品組成：
兔磷酸化酶b(1),67 µg,分子量(Mr) 97 000
牛血清白蛋白(2),83 µg,分子量(Mr) 66 000
雞卵清蛋白(3),147 µg,分子量(Mr) 45 000
牛血碳酸酐酶(4),83 µg,分子量(Mr) 30 000
大豆胰蛋白酶抑制劑(5),80 µg,分子量(Mr) 20 100
牛奶α-乳白蛋白(6),116 µg, 分子量(Mr) 14 400
分子量檢測(cè)范圍：
14-97kDa。
儲(chǔ)存條件：
4℃，密封儲(chǔ)存。
GE低分子量蛋白標(biāo)準(zhǔn)(GE17-0446-01)使用說(shuō)明書分子生物學(xué)領(lǐng)域：
涉及核酸純化、常用分子生物學(xué)試劑、PCR等相關(guān)試劑盒。
分子生物學(xué)試劑：擁有的價(jià)格優(yōu)勢(shì)，品質(zhì)可信賴，市場(chǎng)占比龐大。
GE低分子量蛋白標(biāo)準(zhǔn)(GE17-0446-01)使用說(shuō)明書收貨注意事項(xiàng)：
當(dāng)您收到貨物后，請(qǐng)仔細(xì)檢查產(chǎn)品的名稱、數(shù)量、質(zhì)量規(guī)格是否與您訂購(gòu)產(chǎn)品*。若產(chǎn)生異議，請(qǐng)及時(shí)與我司。按照我司指令及時(shí)將貨物退回，我司*時(shí)間為您安排配送正確貨物。請(qǐng)您務(wù)必保證退還貨物的包裝完整性。
當(dāng)您收到貨物后，若發(fā)現(xiàn)包裝破損，產(chǎn)品泄露等意外情況，請(qǐng)及時(shí)拍照留證，并將照片傳回我司，我司確認(rèn)后，將及時(shí)為您更換新的貨物，原有貨物按照我司指令處理。
我司默認(rèn)貨物簽收24小時(shí)內(nèi)無(wú)反饋，即視為您已經(jīng)認(rèn)同我司到貨情況，未出現(xiàn)包裝破損、貨物錯(cuò)誤等問(wèn)題。
因大多情況貨物是以快遞形式配送，請(qǐng)盡量本人簽收，如由您認(rèn)同的其他人或第三方代為簽收，也認(rèn)同與您本人簽收具有相同的效力，如24小時(shí)內(nèi)無(wú)反饋，默認(rèn)貨物完整正確送達(dá)。
我司所有產(chǎn)品的質(zhì)量追溯期為90天，若有質(zhì)量異議，請(qǐng)務(wù)必在90天內(nèi)提出，超過(guò)90天后，我司默認(rèn)貴處已經(jīng)認(rèn)同該產(chǎn)品的質(zhì)量。
25g 瓶 Tetrabutylammonium hydrogen sulfate 四丁基硫酸氫銨
100g 瓶 Tetrabutylammonium hydrogen sulfate 四丁基硫酸氫銨
1g 瓶 Alizarin Fluorine Blue 茜素絡(luò)合指示劑
5g 瓶 Alizarin Fluorine Blue 茜素絡(luò)合指示劑
25g 瓶 4-Amino-benzenesulfonic acid monosodium salt 對(duì)氨基苯磺酸鈉
100g 瓶 4-Amino-benzenesulfonic acid monosodium salt 對(duì)氨基苯磺酸鈉
1mg 瓶 PMA 佛波酯
5mg 瓶 PMA 佛波酯
1g 瓶 3,3'-Diaminobenzidine 3,3'-二氨基二苯胺
25g 瓶 Creatine monohydrate 一水肌酸
100g 瓶 Creatine monohydrate 一水肌酸
5g 瓶 Trilaurin 甘油三酯
250mg 瓶 Rosiglitazone 羅格列酮堿
10g 瓶 Dimethyl Dodecanedioate 十二碳二酸二甲酯
Nexclusion. Monoubiquitination of one of either Lys-13 and Lys-289 amino acid is sufficient to modulate PTEN compartmentalization. Ubiquitinated by XIAP/BIRC4.
DISEASE : Defects in PTEN are a cause of Cowden disease (CD) [MIM:158350]; also known as Cowden syndrome (CS). CD is an autosomal dominant cancer predisposition syndrome associated with elevated risk for tumors of the breast, thyroid and skin. The predominant phenotype for CD is multiple hamartoma syndrome, in many organ systems including the breast (70% of CD patients), thyroid (40-60%), skin, CNS (40%), gastrointestinal tract. Affected individuals are at an increased risk of both breast and thyroid cancers. Trichilemmomas (benign tumors of the hair follicle infundibulum), and mucocutaneous papillomatosis (99%) are hallmarks of CD.
Defects in PTEN are the cause of Lhermitte-Duclos disease (LDD) [MIM:158350]; also known as cerebelloparenchymal disorder VI. LDD is characterized by dysplastic gangliocytoma of the cerebellum which often results in cerebellar signs and seizures. LDD and CD seem to be the same entity, and are considered as hamartoma-neoplasia syndromes.
GE低分子量蛋白標(biāo)準(zhǔn)(GE17-0446-01)使用說(shuō)明書Defects in PTEN are a cause of Bannayan-Zonana syndrome (BZS) [MIM:153480]; also known as Ruvalcaba-Myhre-Smith syndrome (RMSS) or Bannayan-Riley-Ruvalcaba syndrome (BRRS). In BZS there seems not to be an increased risk of malignancy. It has a partial clinical overlap with CD. BZS is characterized by the classic triad of macrocephaly, lipomatosis and pigmented macules of the gland penis.
